|
RPL23AP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.374650E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.420200E-01 |
| Normal-vs-Stage2 |
8.558200E-01 |
| Normal-vs-Stage3 |
6.043600E-01 |
| Normal-vs-Stage4 |
8.492000E-01 |
| Stage1-vs-Stage2 |
5.282800E-01 |
| Stage1-vs-Stage3 |
7.903400E-01 |
| Stage1-vs-Stage4 |
7.027200E-01 |
| Stage2-vs-Stage3 |
7.327200E-01 |
| Stage2-vs-Stage4 |
9.443800E-01 |
| Stage3-vs-Stage4 |
8.587400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.664100E-02 |
| Normal-vs-AfricanAmerican |
6.847200E-01 |
| Normal-vs-Asian |
3.834400E-01 |
| Caucasian-vs-AfricanAmerican |
8.827000E-04 |
| Caucasian-vs-Asian |
9.884800E-01 |
| AfricanAmerican-vs-Asian |
2.796000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.356400E-01 |
| Normal-vs-Female |
4.649500E-02 |
| Male-vs-Female |
8.007900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.724800E-01 |
| Normal-vs-Extreme_Weight |
2.555200E-01 |
| Normal-vs-Obese |
3.415800E-01 |
| Normal-vs-Extreme_Obese |
3.563000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.059400E-01 |
| Normal_Weight-vs-Obese |
6.610200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.875000E-01 |
| Extreme_Weight-vs-Obese |
9.737600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.831600E-01 |
| Obese-vs-Extreme_Obese |
5.807600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.008820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.213190E-01 |
| Normal-vs-Age(61-80Yrs) |
2.445400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.656200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.546800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.582800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.801200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.657600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.508200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.586600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.274200E-02 |
| Normal-VS-Type2 PRCC |
6.784200E-01 |
| Normal-VS-KIRP CIMP |
3.517400E-01 |
| Normal-VS-Unclassified PRCC |
4.442300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.175600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.661400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.149200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.162200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.192100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.103400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.901800E-01 |
| Normal-vs-N1 |
4.203600E-01 |
| Normal-vs-N2 |
6.363400E-01 |
| N0-vs-N1 |
9.824800E-01 |
| N0-vs-N2 |
9.801000E-01 |
| N1-vs-N2 |
9.757600E-01 |
|
|
